New drug shows promise in fight against sudden, severe hair loss
Disease control
Ongoing
This clinical trial is testing whether an investigational drug called bempikibart can help regrow hair in adults with severe alopecia areata, a condition that causes sudden, patchy hair loss. The study involves injections given every two weeks and measures hair regrowth over many…
Phase: PHASE2 • Sponsor: Q32 Bio Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC